Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.24 Down 0.45(3.06%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 620   980   97   2,414  
Cost of Revenue -   -   -   -  
Gross Profit 620   980   97   2,414  
Operating Expenses
Research Development17,804  20,417  15,090  14,090  
Selling General and Administrative4,677  3,579  3,411  3,138  
Non Recurring -   -   -  2,334  
Others253  253  254  253  
Total Operating Expenses -   -   -  19,815  
Operating Income or Loss (22,114) (23,269) (18,658) (17,401)
Income from Continuing Operations
Total Other Income/Expenses Net137  142  161  379  
Earnings Before Interest And Taxes(21,977)(23,127)(18,497)(17,022)
Interest Expense85  13  519  310  
Income Before Tax(22,062)(23,140)(19,016)(17,332)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(22,062)(23,140)(19,016)(17,332)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (22,062) (23,140) (19,016) (17,332)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (22,062) (23,140) (19,016) (17,332)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.